يعرض 1 - 20 نتائج من 61 نتيجة بحث عن '"Soriano-Pérez, Manuel Jesús"', وقت الاستعلام: 0.48s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
  3. 3
    Academic Journal
  4. 4
    Academic Journal

    المساهمون: Institut Català de la Salut, Tamarozzi F, Rodari P Department of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy. Salas-Coronas J, Soriano-Pérez MJ Tropical Medicine Unit, Hospital de Poniente, El Ejido, Almería, Spain. Bottieau E Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. Salvador F, Treviño B Unitat de Medicina Tropical i Salut Internacional Drassanes-Vall d'Hebron Hospital Universitari, Barcelona, Spain. Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS Barcelona, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Travel Medicine;29(7); https://doi.org/10.1093/jtm/taac048; Tamarozzi F, Rodari P, Salas-Coronas J, Bottieau E, Salvador F, Soriano-Pérez MJ, et al. A large case series of travel-related Mansonella perstans (vector-borne filarial nematode): a TropNet study in Europe. J Travel Med. 2022 Oct;29(7):1–9.; https://hdl.handle.net/11351/8554; 000789027000001

  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
  8. 8
  9. 9
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal

    المساهمون: Universidad de Sevilla. Departamento de Microbiología, Ministerio de Sanidad y Consumo. España, European Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER)

    Relation: Journal of Clinical Microbiology, 46 (4), 1558-1560.; REIPI RD06/0008; http://dx.doi.org/10.1128/JCM.02066-07; https://idus.us.es/handle/11441/63345

  13. 13
  14. 14
    Dissertation/ Thesis
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
  19. 19
    Academic Journal

    المصدر: Biomedica; Vol. 38 No. 4 (2018); 456-462 ; Biomédica; Vol. 38 Núm. 4 (2018); 456-462 ; 2590-7379 ; 0120-4157

    وصف الملف: application/pdf; application/xml

    Relation: https://revistabiomedica.org/index.php/biomedica/article/view/3893/4144; https://revistabiomedica.org/index.php/biomedica/article/view/3893/4216; Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol. 1993;15:92-8.; Larroche C, Spivak JL. Pathogenesis of hemophagocytic syndrome. Autoimmune Rev. 2004;3:69-75. https://doi.org/10.1016/S1568-9972(03)00091-0; D´Agati VD, Fogo AB, Bruijin JA, Jenette JC. Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis. 2004;43:368-82. https://doi.org/10.1053/j.ajkd.2003.10.024; Verbsky JM, Grossman WJ. Hemophagocytic lymphohistiocytosis: Diagnosis, pathophysiology, treatment, and future perspectives. Ann Med. 2006;38:20-31. https://doi.; org/10.1080/07853890500465189; Kumukura S, Murakawa Y. Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol. 2014;66:2297-307. https://doi.org/10.1002/art.38672; Trottestam H, Horne A, Arico M, Egeler RM, Filipovich AH, Gadner H, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: Long-term results of the HLH-94 treatment protocol. Blood. 2011;118:4577-84. https://doi.org/10.1182/blood-2011-06-356261; Aulagnon F, Lapidus N, Canet E, Galicier L, Boutboul D, Peraldi MN, et al. Acute kidney injury in adults with hemophagocytic lymphohistiocytosis. Am J Kidney Dis. 2015;65:851-9. https://doi.org/10.1053/j.ajkd.2014.10.012; Karras A. What nephrologists need to know about hemophagocytic syndrome. Nat Rev Nephrol. 2009;5:329-36. https://doi.org/10.1038/nrneph.2009.73; Málaga-Dieguez L, Ming W, Trachtman H. Direct reversible kidney injury in familial hemophagocytic lymphohistiocytosis type 3. J Am Soc Nephrol. 2015;26:1777-80. https://doi.org/10.1681/ASN.2014111090; Thaunat O, Delahoisse M, Fakhouri F, Martínez F, Stephan JL, Noël LH, et al. Nephrotic syndrome associated with hemophagocytic syndrome. Kidney Int. 2006;69:1892-; Esmaili H, Mostafidi E, Mehramuz B, Ardalan M, Mohajel-Shoja M. An update on renal involvement in hemophagocytic syndrome (macrophage activation syndrome). J Nephropathol. 2016;5:8-14. https://doi.org/10.15171/jnp.2016.02; Santoriello D, Hogan H, DÁgati VD. Hemophagocytic syndrome with histiocytic glomerulopathy and intraglomerular hemophagocytosis. Am J Kidney Dis. 2016;67:978-83.; Ponticelli C, Alberighi OD. Haemophagocytic syndrome--a life-threatening complication of renal transplantation. Nephrol Dial Transplant. 2009;24:2623-7. https://doi.org/10.1093/ndt/gfp282; Raffray L, Couzi L, Viallard JF, Pellegrin JL, Augis V, Vernant JP, et al. Mycophenolate mofetil: A possible cause of hemophagocytic syndrome following renal transplantation? Am J Transplant. 2010;10:2378-9. https://doi.org/10.1111/j.1600-6143.2010.03254.x; Nichols B, Jog P, Lee JH, Blackler D, Wilmot M, Dágit V, et al. Innate immunity pathways regulate the nephropathy gene apolipoprotein L1. Kidney Int. 2015;87:332-42. https://doi.org/10.1038/ki.2014.270; Genovese G, Tonna SJ, Know AU, Appel GB, Katz A, Bernhardy AJ, et al. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int. 2010;78:698-704. https://doi.org/10.1038/ki.2010.251; Redondo-Pachón MD, Ortega-Salas R, Moyano-Peregrin C, López-Andreu M, Espinosa-Hernández M, Romera-Segorbe A, et al. Marcadores de desdiferenciacion podocitaria en un paciente con glomerulonefritis colapsante.Nefrología. 2010;30:360-6. https://doi.org/10.3265/Nefrologia.pre2010.Mar.10325; Albaqumi M, Barisoni L. Current views on collapsing glomerulopathy. J Am Soc Nephrol. 2008;19:1276-81. https://doi.org/10.1681/ASN.2007080926; Koukouritaki SB, Vardaki EA, Papakonstanti EA, Lianos E, Stournaras C, Emmanouel DS. TNF-alpha induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase. Mol Med. 1999;5:382-92.; Markowitz GS, Nasr SH, Stokes MB, D´Agati VD. Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2010;5:607-15. https://doi.org/10.2215/CJN.07311009; Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev. 2003;83:253-307. https://doi.org/10.1152/physrev.00020.2002; Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D´Agati V, Alpers CE. Differential expression of cyclindependent kinase inhibitors in human glomerular disease: Role in podocyte proliferation and maturation. Kidney Int. 2000;58:674-83. https://doi.org/10.1046/j.1523-1755.2000.00213.x; Barisona L, Nelson PJ. Collapsing glomerulopathy: An inflammatory podocytopathy? Curr Opin Nephrol Hypertens. 2007;16:192-5. https://doi.org/10.1097/MNH.0b 013e; 32805b726b; Schwimmer JA, Markowitz GS, Valeri A, Appel GB. Collapsing glomerulopathy. Semin Nephrol. 2003;23:209-18.; Grcevska L, Polenakovik M. Collapsing glomerulopathy: Clinical characteristic and follow-up. Am J Kidney Dis. 1999;33:652-57. https://doi.org/10.1053/snep.2003.50019; Kashgary A, Sontrop JM, Li L, Al-Jaishi AA, Habibullah ZN, Alsolaimani R. The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series. BMC Nephrol. 2016;17:104. https://doi.org/10.1186/s12882-016-0322-7; Asci G, Toz H, Ozkahya M, Cagirgan S, Duman S, Sezis M, et al. High-dose immunoglobulin therapy in renal transplant recipients with hemophagocytic histiocytic syndrome. J Nephrol. 2006;19:322-6.; Ferreri AJM, Govi S, Pilari SA. Hepatosplenic gamma-delta T-cell lymphoma. Crit Rev Oncol Hematol. 2012;83:283-292. https://doi.org/10.1016/j.critrevonc.2011.10.001; Han AR, Lee HR, Park BB, Hwang IG, Park S, Lee SC, et al. Lymphoma-associated hemophagocytic syndrome: Clinical features and treatment outcome. Ann Hematol. 2007;86:493-8. https://doi.org/10.1007/s00277-007-0278-6; Egües-Dubuc C, Aldasoro-Cáceres V, Uriarte-Ecenarro M, Errazquin-Aguirre N, Hernando-Rubio I, Meneses-Villalba CF, et al. Síndrome de activación macrofágica secundario a enfermedades autoinmunes, hematológicas, infecciosas y oncológicas. Serie de 13 casos clínicos y una revisión bibliográfica. Reumatol Clin. 2015;11:139-43. https://doi.org/10.1016/j.reuma.2014.06.007; https://revistabiomedica.org/index.php/biomedica/article/view/3893

  20. 20
    Academic Journal